0001104659-19-032914.txt : 20190530 0001104659-19-032914.hdr.sgml : 20190530 20190530212555 ACCESSION NUMBER: 0001104659-19-032914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190528 FILED AS OF DATE: 20190530 DATE AS OF CHANGE: 20190530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARLAND DEBORAH CENTRAL INDEX KEY: 0001777210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19868371 MAIL ADDRESS: STREET 1: C/O BICYCLE THERAPEUTICS LIMITED STREET 2: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB44 3AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 a4.xml 4 X0306 4 2019-05-28 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001777210 HARLAND DEBORAH C/O S.R. ONE, LIMITED 161 WASHINGTON STREET, SUITE 500 CONSHOHOCKEN PA 19428 1 0 0 0 Ordinary Shares 2019-05-28 4 C 0 893195 A 893195 I See Footnote Ordinary Shares 2019-05-28 4 C 0 636366 A 1529561 I See Footnote Ordinary Shares 2019-05-28 4 P 0 385714 14 A 1915275 I See Footnote Series A Preferred Shares 2019-05-28 4 C 0 893195 D Ordinary Shares 893195 0 I See Footnote Series B1 Preferred Shares 2019-05-28 4 C 0 636366 D Ordinary Shares 636366 0 I See Footnote Each Series A and B1 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of the shares reported herein. Deborah Harland holds the title of Vice President at S.R. One, Limited and is an employee of GlaxoSmithKline Services Unlimited, a wholly-owned subsidiary of GlaxoSmithKline plc. Ms. Harland disclaims beneficial ownership of all the shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of her pecuniary interest therein. /s/ Lee Kalowski, as Attorney-in-Fact 2019-05-30